Filter
Exclude
Time range
-
Near
ACPMP's grant application is open for the 2026 Changemaker Grant! The 2-year, $150,000 grant supports research aimed at advancing progress in appendix cancer and pseudomyxoma peritonei (PMP). Learn more at acpmp.org/research/150000-ch… #AppendixCancer
42
Meet Tom Lerma: #appendixcancer survivor and co-host of the California Appendix Cancer State Walk on June 13th. 18 months ago, he wasn't sure this day would come. Now he's walking for those who can't. Register or Donate: secure.acpmp.org/event/the-2…
47
An amazing day indeed @ASCO #ASCO2026! And an opportunity for other RAS dependent diseases including #rarecancers such as #appendixcancer @APeritoneum
31 May 2026, Chicago Full #HallB1 at @ASCO #ASCO26 #Daraxonrasib doubles both #OS and #PFS for advanced #PDAC - paradigm change I feel honoured to be in this room today 🙌🏻 🔬Science means hope🧬 And this bit of hope goes to #PDAC💜 🗓️Now: access 💪 @P_C_E_ @ACanPan @myESMO
1
3
88
Feeling excited for the upcoming @AmCollSurgeons (ACS) Clinical Congress 2026 in DC! 🏛️ Looking forward to sharing our latest findings on quality of life in CRS/HIPEC patients and connecting with colleges and mentors. #OvarianCancer #AppendixCancer #ACSCC26
4
132
Starting round 3! Thank you for the dorky corgi warmie! Thank you for continued prayers! Fundraisers- Medical- gofund.me/e74f28ef Travel- fundmytravel.com/campaign/bI… #cancerfighter #CANCERSUCKS #rarecancer #appendixcancer
3
5
81
Applications for 2026 ACPMP Changemaker Grant open May 15th! We are funding a 2yr $150K grant for #appendixcancer & PMP research. Priority areas include tumor biology, novel therapeutics, molecular characterization, biomarkers, and diagnostics. acpmp.org/research/150000-ch…
4
6
598
John Paul Shen (@jpshen_md) breaks down the unique biology of #AppendixCancer, a rare, heterogeneous GI tumor. Low-grade disease shows limited chemo response but better survival, while spread often stays intra-abdominal vs liver mets in colon cancer. Key insights for care 🩺 Watch: ow.ly/QNf950YJPKv #oncology #gism This video is available on the GI Cancer Channel on VJOncology, an independent medical education platform, which is supported by Gilead Sciences (Silver) and Revolution Medicines (Silver). Supporters have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
1
3
6
3,247
Honoured for having the opportunity to present some of our work @DrRaghavendar @azizosurgeon on #appendixcancer at #ESMORareCancers26 Glad to see you back @MaddyStrach and Prof Deraco Thank you @KaiKeenShiu and Lucjan Wyrwicz for moderating the session! @H12Octubre @myESMO
1
3
24
2,758
The first dedicated #AppendixCancer Patient-Powered Registry is advancing research through real-world data. Participation helps researchers better understand diagnosis, treatment, and survivorship. Learn more: acpmpregistry.iamrare.org/
1
5
244
On @rarediseaseday, we’re proud to spotlight a new free #CME course developed in partnership w/ @MedicalCollege and led by @umaduekwemd : The Neoplastic Appendix: When to Watch, When to Act, When to Refer. Learn more & Register here: ocpe.mcw.edu/node/229093... #AppendixCancer
8
177
Join us on Thursday, January 29th, at 7 PM for upcoming webinar: HIPEC vs. PIPAC: Exploring a New Clinical Trial for #AppendixCancer Patients Not Eligible for Cytoreductive Surgery, led by Dr. Wagner & Dr. Altpeter of @AHNtoday Register Today: acpmp.org/hipecvspipac
3
7
484
Recent data show that rates of #AppendixCancer in the U.S. have risen faster among Gen Xers and millennials compared with older generations. ow.ly/3cSq50XNNIH
3
344
🎄 Happy Holidays! This season, we celebrate hope, community and the progress being made in #appendixcancer research. Your support brings us closer to better treatments and a brighter future for patients and families. 💛 Thank you for being part of the journey!
3
50